Susquehanna International Group
FUSN

Susquehanna International Group’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Susquehanna International Group’s Portfolio FUSN Stock Details FUSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-147,547
Closed -$3.15M – 13518
2024
Q1 		$3.15M Buy
147,547
+129,082
+699% +$1.54M ﹤0.01% 4434
2023
Q4 		$177K Buy
+18,465
New +$89.7K ﹤0.01% 10802
2021
Q2 		– Sell
-10,745
Closed -$115K – 13435
2021
Q1 		$115K Buy
+10,745
New +$126K ﹤0.01% 11787

Susquehanna International Group's FUSN Position: Q2 2024 in Review

Susquehanna International Group sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 147,547 shares — an estimated $3.15M sold.

Susquehanna International Group first reported a position in FUSN in Q1 2021 and held it in 3 quarters. The position peaked at $3.15M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

  • Susquehanna International Group reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
  • Susquehanna International Group sold 147,547 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $3.15M.
  • Susquehanna International Group first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2021 and held it in 3 quarters.
  • Susquehanna International Group's Fusion Pharmaceuticals Inc. Common Shares position peaked at $3.15M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.